Annual Net Income
-$760.50 M
-$548.90 M-259.40%
31 December 2023
Summary:
Emergent BioSolutions annual net profit is currently -$760.50 million, with the most recent change of -$548.90 million (-259.40%) on 31 December 2023. During the last 3 years, it has fallen by -$1.07 billion (-348.69%). EBS annual net income is now -348.69% below its all-time high of $305.80 million, reached on 31 December 2020.EBS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$114.80 M
+$397.90 M+140.55%
30 September 2024
Summary:
Emergent BioSolutions quarterly net profit is currently $114.80 million, with the most recent change of +$397.90 million (+140.55%) on 30 September 2024. Over the past year, it has increased by +$378.20 million (+143.58%). EBS quarterly net income is now -38.31% below its all-time high of $186.10 million, reached on 31 December 2020.EBS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$208.80 M
+$378.20 M+64.43%
30 September 2024
Summary:
Emergent BioSolutions TTM net profit is currently -$208.80 million, with the most recent change of +$378.20 million (+64.43%) on 30 September 2024. Over the past year, it has increased by +$569.20 million (+73.16%). EBS TTM net income is now -153.81% below its all-time high of $388.00 million, reached on 31 March 2021.EBS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -259.4% | +143.6% | +73.2% |
| 3 y3 years | -348.7% | +451.1% | -191.7% |
| 5 y5 years | -1312.9% | +165.7% | -5071.4% |
EBS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -348.7% | at low | -35.5% | +140.6% | -191.7% | +73.2% |
| 5 y | 5 years | -348.7% | at low | -38.3% | +140.6% | -153.8% | +73.2% |
| alltime | all time | -348.7% | at low | -38.3% | +140.6% | -153.8% | +73.2% |
Emergent BioSolutions Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $114.80 M(-140.6%) | -$208.80 M(-64.4%) |
| June 2024 | - | -$283.10 M(-3245.6%) | -$587.00 M(+3.8%) |
| Mar 2024 | - | $9.00 M(-118.2%) | -$565.30 M(-25.7%) |
| Dec 2023 | -$760.50 M(+259.4%) | -$49.50 M(-81.2%) | -$760.50 M(-2.2%) |
| Sept 2023 | - | -$263.40 M(+0.8%) | -$778.00 M(+29.3%) |
| June 2023 | - | -$261.40 M(+40.4%) | -$601.70 M(+51.7%) |
| Mar 2023 | - | -$186.20 M(+177.9%) | -$396.70 M(+85.2%) |
| Dec 2022 | -$211.60 M(-196.4%) | -$67.00 M(-23.1%) | -$214.20 M(-797.7%) |
| Sept 2022 | - | -$87.10 M(+54.4%) | $30.70 M(-63.9%) |
| June 2022 | - | -$56.40 M(+1424.3%) | $85.10 M(-41.8%) |
| Mar 2022 | - | -$3.70 M(-102.1%) | $146.10 M(-33.4%) |
| Dec 2021 | $219.50 M(-28.2%) | $177.90 M(-644.0%) | $219.50 M(-3.6%) |
| Sept 2021 | - | -$32.70 M(-810.9%) | $227.70 M(-24.1%) |
| June 2021 | - | $4.60 M(-93.4%) | $299.90 M(-22.7%) |
| Mar 2021 | - | $69.70 M(-62.5%) | $388.00 M(+26.9%) |
| Dec 2020 | $305.80 M(+461.1%) | $186.10 M(+371.1%) | $305.80 M(+83.6%) |
| Sept 2020 | - | $39.50 M(-57.4%) | $166.60 M(-2.2%) |
| June 2020 | - | $92.70 M(-841.6%) | $170.30 M(+150.1%) |
| Mar 2020 | - | -$12.50 M(-126.7%) | $68.10 M(+24.7%) |
| Dec 2019 | $54.50 M(-13.1%) | $46.90 M(+8.6%) | $54.60 M(+1200.0%) |
| Sept 2019 | - | $43.20 M(-554.7%) | $4.20 M(-123.2%) |
| June 2019 | - | -$9.50 M(-63.5%) | -$18.10 M(-143.6%) |
| Mar 2019 | - | -$26.00 M(+642.9%) | $41.50 M(-33.7%) |
| Dec 2018 | $62.70 M(-24.1%) | -$3.50 M(-116.7%) | $62.60 M(-37.4%) |
| Sept 2018 | - | $20.90 M(-58.3%) | $100.05 M(-11.2%) |
| June 2018 | - | $50.10 M(-1122.4%) | $112.70 M(+67.7%) |
| Mar 2018 | - | -$4.90 M(-114.4%) | $67.22 M(-18.6%) |
| Dec 2017 | $82.60 M(+59.5%) | $33.95 M(+1.2%) | $82.60 M(-4.0%) |
| Sept 2017 | - | $33.55 M(+626.8%) | $86.07 M(+16.5%) |
| June 2017 | - | $4.62 M(-56.0%) | $73.86 M(+26.7%) |
| Mar 2017 | - | $10.48 M(-72.0%) | $58.29 M(+12.5%) |
| Dec 2016 | $51.80 M(-17.6%) | $37.42 M(+75.3%) | $51.80 M(+8.5%) |
| Sept 2016 | - | $21.34 M(-294.9%) | $47.73 M(-24.6%) |
| June 2016 | - | -$10.95 M(-374.3%) | $63.33 M(-28.3%) |
| Mar 2016 | - | $3.99 M(-88.0%) | $88.38 M(+40.6%) |
| Dec 2015 | $62.87 M(+71.1%) | $33.35 M(-9.7%) | $62.87 M(+5.4%) |
| Sept 2015 | - | $36.94 M(+162.0%) | $59.64 M(+33.9%) |
| June 2015 | - | $14.10 M(-165.5%) | $44.53 M(+25.6%) |
| Mar 2015 | - | -$21.52 M(-171.5%) | $35.46 M(-3.5%) |
| Dec 2014 | $36.74 M(+18.0%) | $30.12 M(+37.9%) | $36.74 M(+68.2%) |
| Sept 2014 | - | $21.83 M(+334.1%) | $21.85 M(+61.8%) |
| June 2014 | - | $5.03 M(-124.9%) | $13.51 M(-28.8%) |
| Mar 2014 | - | -$20.24 M(-232.9%) | $18.96 M(-39.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $31.14 M(+32.4%) | $15.22 M(+12.8%) | $31.14 M(-2.8%) |
| Sept 2013 | - | $13.49 M(+28.7%) | $32.02 M(+27.3%) |
| June 2013 | - | $10.48 M(-230.0%) | $25.15 M(+12.8%) |
| Mar 2013 | - | -$8.06 M(-150.1%) | $22.29 M(-5.2%) |
| Dec 2012 | $23.52 M(+2.2%) | $16.11 M(+143.4%) | $23.53 M(-34.8%) |
| Sept 2012 | - | $6.62 M(-13.3%) | $36.08 M(+16.3%) |
| June 2012 | - | $7.63 M(-211.8%) | $31.01 M(-17.5%) |
| Mar 2012 | - | -$6.83 M(-123.8%) | $37.59 M(+63.3%) |
| Dec 2011 | $23.02 M(-55.5%) | $28.66 M(+1750.0%) | $23.02 M(+11.7%) |
| Sept 2011 | - | $1.55 M(-89.1%) | $20.61 M(-36.0%) |
| June 2011 | - | $14.21 M(-166.4%) | $32.18 M(+15.8%) |
| Mar 2011 | - | -$21.40 M(-181.5%) | $27.78 M(-46.3%) |
| Dec 2010 | $51.70 M(+66.0%) | $26.25 M(+100.1%) | $51.70 M(+74.2%) |
| Sept 2010 | - | $13.12 M(+33.8%) | $29.68 M(+69.5%) |
| June 2010 | - | $9.81 M(+288.7%) | $17.51 M(-22.3%) |
| Mar 2010 | - | $2.52 M(-40.4%) | $22.55 M(-27.6%) |
| Dec 2009 | $31.14 M(+50.6%) | $4.23 M(+346.2%) | $31.14 M(+9.8%) |
| Sept 2009 | - | $949.00 K(-93.6%) | $28.36 M(-25.0%) |
| June 2009 | - | $14.84 M(+33.5%) | $37.80 M(+52.6%) |
| Mar 2009 | - | $11.12 M(+664.2%) | $24.77 M(+19.8%) |
| Dec 2008 | $20.68 M(-9.8%) | $1.46 M(-86.0%) | $20.68 M(-56.0%) |
| Sept 2008 | - | $10.39 M(+472.2%) | $46.97 M(+19.1%) |
| June 2008 | - | $1.81 M(-74.2%) | $39.42 M(+20.8%) |
| Mar 2008 | - | $7.02 M(-74.7%) | $32.65 M(+42.4%) |
| Dec 2007 | $22.94 M(+0.6%) | $27.74 M(+875.1%) | $22.93 M(+7.6%) |
| Sept 2007 | - | $2.85 M(-157.3%) | $21.32 M(-6.6%) |
| June 2007 | - | -$4.96 M(+84.4%) | $22.83 M(-14.4%) |
| Mar 2007 | - | -$2.69 M(-110.3%) | $26.68 M(-5.6%) |
| Dec 2006 | $22.79 M(+44.4%) | $26.13 M(+500.1%) | $28.26 M(+142.3%) |
| Sept 2006 | - | $4.35 M(-491.5%) | $11.66 M(+24.2%) |
| June 2006 | - | -$1.11 M(0.0%) | $9.39 M(-25.4%) |
| Mar 2006 | - | -$1.11 M(-111.7%) | $12.59 M(-20.2%) |
| Dec 2005 | $15.78 M(+37.6%) | $9.53 M(+357.4%) | $15.78 M(+73.1%) |
| Sept 2005 | - | $2.08 M(0.0%) | $9.12 M(-7.9%) |
| June 2005 | - | $2.08 M(0.0%) | $9.90 M(-7.3%) |
| Mar 2005 | - | $2.08 M(-27.3%) | $10.69 M(-6.8%) |
| Dec 2004 | $11.47 M(+157.6%) | $2.87 M(0.0%) | $11.47 M(+33.3%) |
| Sept 2004 | - | $2.87 M(0.0%) | $8.60 M(+50.0%) |
| June 2004 | - | $2.87 M(0.0%) | $5.74 M(+100.0%) |
| Mar 2004 | - | $2.87 M | $2.87 M |
| Dec 2003 | $4.45 M(-87.8%) | - | - |
| Dec 2002 | $36.39 M(-6669.0%) | - | - |
| Dec 2001 | -$554.00 K | - | - |
FAQ
- What is Emergent BioSolutions annual net profit?
- What is the all time high annual net income for Emergent BioSolutions?
- What is Emergent BioSolutions annual net income year-on-year change?
- What is Emergent BioSolutions quarterly net profit?
- What is the all time high quarterly net income for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly net income year-on-year change?
- What is Emergent BioSolutions TTM net profit?
- What is the all time high TTM net income for Emergent BioSolutions?
- What is Emergent BioSolutions TTM net income year-on-year change?
What is Emergent BioSolutions annual net profit?
The current annual net income of EBS is -$760.50 M
What is the all time high annual net income for Emergent BioSolutions?
Emergent BioSolutions all-time high annual net profit is $305.80 M
What is Emergent BioSolutions annual net income year-on-year change?
Over the past year, EBS annual net profit has changed by -$548.90 M (-259.40%)
What is Emergent BioSolutions quarterly net profit?
The current quarterly net income of EBS is $114.80 M
What is the all time high quarterly net income for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly net profit is $186.10 M
What is Emergent BioSolutions quarterly net income year-on-year change?
Over the past year, EBS quarterly net profit has changed by +$378.20 M (+143.58%)
What is Emergent BioSolutions TTM net profit?
The current TTM net income of EBS is -$208.80 M
What is the all time high TTM net income for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM net profit is $388.00 M
What is Emergent BioSolutions TTM net income year-on-year change?
Over the past year, EBS TTM net profit has changed by +$569.20 M (+73.16%)